Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Huttner

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Eclinicalmedicine|December 9, 2022
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysisAdi Turjeman, Elodie von Dach, José Molina, et al.
Revue Medicale Suisse|January 14, 2021
Aude Nguyen, Klara Posfay-Barbe, Géraldine Blanchard-Rohner, et al.
Intensive Care Medicine|January 2, 2023
How to use biomarkers of infection or sepsis at the bedside: guide to cliniciansPedro Póvoa, Luís Coelho, Felipe Dal-Pizzol, et al.
European Journal of Clinical Investigation|May 22, 2022
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceArnaud G L'Huillier, Sabrina Pagano, Stephanie Baggio, et al.
Journal of Clinical Immunology|September 28, 2021
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsDiem-Lan Vu, Paola Martinez-Murillo, Fiona Pigny, et al.
NPJ Vaccines|April 28, 2020
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationDavid Pejoski, Casimir de Rham, Paola Martinez-Murillo, et al.
NPJ Vaccines|October 21, 2020
Erratum: Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationDavid Pejoski, Casimir de Rham, Paola Martinez-Murillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2026
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the WorldAbi Manesh, Abdullah T Aslan, Mithun Mohan George, et al.
JAMA|June 3, 2020
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical TrialElodie von Dach, Werner C Albrich, Anne-Sophie Brunel, et al.
Pharmaceutics|December 28, 2021
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill PatientsFemke de Velde, Brenda C M de Winter, Michael N Neely, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Eclinicalmedicine|December 9, 2022
Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysisAdi Turjeman, Elodie von Dach, José Molina, et al.
Revue Medicale Suisse|January 14, 2021
Aude Nguyen, Klara Posfay-Barbe, Géraldine Blanchard-Rohner, et al.
Intensive Care Medicine|January 2, 2023
How to use biomarkers of infection or sepsis at the bedside: guide to cliniciansPedro Póvoa, Luís Coelho, Felipe Dal-Pizzol, et al.
European Journal of Clinical Investigation|May 22, 2022
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceArnaud G L'Huillier, Sabrina Pagano, Stephanie Baggio, et al.
Journal of Clinical Immunology|September 28, 2021
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsDiem-Lan Vu, Paola Martinez-Murillo, Fiona Pigny, et al.
NPJ Vaccines|April 28, 2020
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationDavid Pejoski, Casimir de Rham, Paola Martinez-Murillo, et al.
NPJ Vaccines|October 21, 2020
Erratum: Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationDavid Pejoski, Casimir de Rham, Paola Martinez-Murillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2026
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the WorldAbi Manesh, Abdullah T Aslan, Mithun Mohan George, et al.
JAMA|June 3, 2020
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical TrialElodie von Dach, Werner C Albrich, Anne-Sophie Brunel, et al.
Pharmaceutics|December 28, 2021
Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill PatientsFemke de Velde, Brenda C M de Winter, Michael N Neely, et al.
Pageof 11